Texas 2023 - 88th Regular

Texas House Bill HR435 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New	Differences
1	1	H.R. No. 435
2	2
3	3
4	4	R E S O L U T I O N
5	5	WHEREAS, Cardiovascular disease is the leading cause of death
6	6	in the United States, and approximately 21 million U.S. patients
7	7	have been diagnosed with atherosclerotic cardiovascular disease,
8	8	indicating that they are at risk of a cardiovascular event; and
9	9	WHEREAS, In Texas, health care professionals have diagnosed
10	10	angina, strokes, heart attacks, or coronary heart diseases for more
11	11	than 1,790,000 adults, and these conditions have been identified as
12	12	manifestations of atherosclerotic cardiovascular disease; in
13	13	addition, over 864,000 adult Texans have reported experiencing a
14	14	heart attack in their lifetime, and more than 798,000 have reported
15	15	experiencing a stroke; the heart disease death rate in Texas is 328
16	16	deaths per 100,000 individuals over the age of 35, surpassing the
17	17	national rate of 319.5; and
18	18	WHEREAS, Research shows that atherosclerotic cardiovascular
19	19	disease is linked to the buildup of cholesterol in the arteries, and
20	20	the risk of cardiovascular events can be reduced by decreasing
21	21	low-density lipoprotein cholesterol (LDL-C) levels; nearly 70
22	22	million U.S. adults had higher than recommended LDL-C levels in
23	23	2016, and more than 43 million U.S. residents are currently being
24	24	treated with lipid-lowering therapies to manage cardiovascular
25	25	risk; statins are one of the leading lipid-lowering therapies, and
26	26	20 percent of atherosclerotic cardiovascular disease patients
27	27	taking statins have achieved healthy levels of LDL-C; and
28	28	WHEREAS, The total direct and indirect cost of
29	29	atherosclerotic cardiovascular disease in the U.S. was $555 billion
30	30	in 2016, and the cost is projected to reach $1.1 trillion by 2035;
31	31	each year, the State of Texas spends an estimated $10.53 billion on
32	32	direct medical expenses for health care related to atherosclerotic
33	33	cardiovascular disease; and
34	34	WHEREAS, Cardiovascular diseases impact the lives of
35	35	countless residents across the state, and it is vital that these
36	36	Texans have access to quality health care; now, therefore, be it
37	37	RESOLVED, That the House of Representatives of the 88th Texas
38	38	Legislature hereby urge the Texas Department of State Health
39	39	Services and the Texas Health and Human Services Commission to
40	40	expand their comprehensive cardiovascular screening programs and
41	41	explore ways to collaborate with federal and national agencies and
42	42	organizations to establish or expand cardiovascular screening
43	43	programs; and, be it further
44	44	RESOLVED, That the Texas cardiovascular plan should be
45	45	updated to enhance the quality of care rendered to patients and
46	46	improve health outcomes; and, be it further
47	47	RESOLVED, That the House of Representatives of the 88th Texas
48	48	Legislature hereby express support for the creation of policies to
49	49	lower the rates of death caused by atherosclerotic cardiovascular
50	50	disease; and, be it further
51	51	RESOLVED, That the chief clerk of the Texas House of
52	52	Representatives forward an official copy of this resolution to the
53	53	commissioners of the Texas Department of State Health Services and
54	54	the Texas Health and Human Services Commission.
55	55	Raymond
56	56	______________________________
57	57	Speaker of the House
58	58	I certify that H.R. No. 435 was adopted by the House on May
59	59	12, 2023, by the following vote: Yeas 143, Nays 0, 2 present, not
60	60	voting.
61	61	______________________________
62	62	Chief Clerk of the House